Temporal arteritis risk factors

Jump to: navigation, search

Temporal Arteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Temporal Arteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Temporal arteritis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Temporal arteritis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Temporal arteritis risk factors

CDC on Temporal arteritis risk factors

Temporal arteritis risk factors in the news

Blogs on Temporal arteritis risk factors

Directions to Hospitals Treating Temporal arteritis

Risk calculators and risk factors for Temporal arteritis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Common risk factors in the development of temporal arteritis may be environmental, genetic, and viral. Common risk factors in the development of temporal arteritis include age, hypertension, and thrombocytosis. Less common risk factors in the development of temporal arteritis include allele HLA-DRB1*04 genetic polymorphisms, varicella zoster virus infection, and smoking.

Risk Factors

The risk factors of temporal arteritis are as follows:

Common Risk Factors

Less Common Risk Factors

References

  1. Nesher G, Berkun Y, Mates M, Baras M, Nesher R, Rubinow A; et al. (2004). "Risk factors for cranial ischemic complications in giant cell arteritis". Medicine (Baltimore). 83 (2): 114–22. PMID 15028965.
  2. González-Gay MA, García-Porrúa C, Llorca J, Hajeer AH, Brañas F, Dababneh A; et al. (2000). "Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients". Medicine (Baltimore). 79 (5): 283–92. PMID 11039076.
  3. Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G; et al. (2005). "Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis". Arthritis Rheum. 53 (2): 293–7. doi:10.1002/art.21075. PMID 15818722.
  4. Mahr, A.; Aouba, A.; Richebé, P.; Gonzalez-Chiappe, S. (2017). "Épidémiologie et histoire naturelle de l'artérite à cellules géantes (Horton)". La Revue de Médecine Interne. 38 (10): 663–669. doi:10.1016/j.revmed.2017.03.007. ISSN 0248-8663.



Linked-in.jpg